Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDividends Paid - CommonDividends Paid - CommonFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neuronetics (STIM) Other financing activities (2018 - 2025)

Neuronetics (STIM) reported Other financing activities of $88000.0 for Q4 2025, down 79.82% year-over-year from $436000.0 in Q4 2024, and up 105.33% on a QoQ basis from -$1.7 million in Q3 2025.

Neuronetics (STIM) has 7 years of Other financing activities data on file, last reported at $88000.0 in Q4 2025.

  • Quarterly Other financing activities fell 79.82% year-over-year to $88000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $168000.0 (down 77.27% YoY) and the FY2025 annual result came in at $168000.0, down 93.6% from the prior year.
  • Other financing activities advanced to $88000.0 in Q4 2025 per STIM's latest filing, from -$1.7 million in the prior quarter.
  • Across five years, Other financing activities topped out at $1.7 million in Q1 2025 and bottomed at -$1.7 million in Q3 2025.
  • The 5-year median for Other financing activities is $88000.0 (2025), against an average of $200000.0.
  • The widest annual swing landed in 2022, when Other financing activities plunged 85.79%; it then jumped 24000.0% in 2023.
  • Tracing STIM's Other financing activities over 5 years: stood at $401000.0 in 2021, then tumbled by 99.75% to $1000.0 in 2022, then jumped by 24000.0% to $241000.0 in 2023, then soared by 80.91% to $436000.0 in 2024, then sank by 79.82% to $88000.0 in 2025.
  • Per Business Quant, the three latest STIM Other financing activities figures stand at $88000.0 (Q4 2025), -$1.7 million (Q3 2025), and $1.7 million (Q1 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn
10 Neuronetics 3.26 Mn -6.42 Mn 16.15 Mn

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 88,000.00
Dec 31, 2025 88,000.00
Sep 30, 2025 -1.65 Mn
Sep 30, 2025 -1.65 Mn
Mar 31, 2025 1.73 Mn
Mar 31, 2025 1.73 Mn
Dec 31, 2024 436,000.00
Dec 31, 2024 436,000.00
Dec 31, 2023 241,000.00
Dec 31, 2023 241,000.00
Jun 30, 2023 62,000.00
Jun 30, 2023 62,000.00
Mar 31, 2023 801,000.00
Mar 31, 2023 801,000.00
Dec 31, 2022 1,000.00
Dec 31, 2022 1,000.00
Jun 30, 2022 33,000.00
Jun 30, 2022 33,000.00
Mar 31, 2022 57,000.00
Mar 31, 2022 57,000.00
Mar 31, 2021 401,000.00
Mar 31, 2021 401,000.00
Dec 31, 2020 100,000.00
Dec 31, 2020 100,000.00
Mar 31, 2020 721,000.00
Mar 31, 2020 721,000.00
Dec 31, 2018 -2,000.00
Dec 31, 2018 -2,000.00
Sep 30, 2018 2.73 Mn
Sep 30, 2018 2.73 Mn
Jun 30, 2018 501,000.00
Jun 30, 2018 501,000.00
Mar 31, 2018 230,000.00
Mar 31, 2018 230,000.00